Delivery Order SPE2DB24D2100-SPE2DB25FBCFG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,417.53 to AmerisourceBergen Drug Corp for the supply of Mercaptopurine 50 mg tablets (250 count) under a firm fixed-price contract. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mercaptopurine 50 mg tablets (250-count units) with a ceiling value of $1,842.80. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mercaptopurine 50 mg tablets. The firm-fixed-price contract has a ceiling value of $3,448.53 and a completion date of September 30, 2024. It is not associated with a set-aside program. Amerisourcebergen, through its extensive supply chain network, will provide this critical medication to support military treatment facilities and other...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,641.84, is for the delivery of 4,568,100 units of the prescription medication mercaptopurine 50 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $1,552.39 firm fixed-price contract is for the supply of Mercaptopurine 50 mg tablets. The contract has an ultimate completion date of December 15, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within the military and...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mercaptopurine 50 MG tablets in 250-count quantities, with a ceiling value of $1,474.24. The delivery order has a firm-fixed price pricing type and is set to be completed by June 10, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,314,186 units of the pharmaceutical drug mercaptopurine 50 mg tablets, with a ceiling value of $2,872.84. The contract has a firm fixed-price pricing type and an ultimate completion date of April 18, 2024. There is no set-aside designation indicated for this award. Amerisourcebergen is a major supplier of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.08, is for the supply of Mercaptopurine 20 mg/mL suspension, a medication used to treat certain types of cancer. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $9,210 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 25 packages of 50mg Mercaptopurine tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 17-18, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency is a combat support agency under the Department of Defense responsible for worldwide...
- The Defense Logistics Agency Troop Support Medical awarded a $2,986.52 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division on September 18, 2023. The order is for the delivery of 250 tablets of 50 mg mercaptopurine to a location in Conshohocken, Pennsylvania, with performance required by September 19, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring and providing nearly all consumable...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBCFGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 13, 2025, for the supply of Mercaptopurine 50 mg tablets in a quantity of 250s, with a ceiling value of $2,211.36. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is set to be completed by February 14, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability across diverse pharmaceutical categories including specialty medications, generic drugs, vaccines, and medical supplies. This delivery order for Mercaptopurine, a chemotherapy medication used in cancer treatment, exemplifies the company's role in supplying essential medications to support military medical readiness and veteran healthcare needs through the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 2/13/25 |